Cite
HARVARD Citation
Takahashi, Y. et al. (n.d.). A phase II trial of the combination of S-1 and paclitaxel followed by 5-FU/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with HER2-negative, stage II/III breast cancer. Breast. pp. S82-. [Online].